Tzafriri AR, Sun YP, Price S, Rogers, C. ‘Systemic and Local Tissue Pharmacokinetics of Single and Overlapping NEVOTM Sirolimus Eluting Stents in the Porcine Coronary Artery Model.’ TCT-433. JACC 2011;58(20s1):B120-B121.
Attizzani GF, Bezzerra HG, Chamie D, Fujino Y, Spognardi AM, Stanley JRL, Yamamoto H, Mehanna E, Wang W, Carlyle WC, McClain JB, Costa MA.’Serial Evaluation of the Vascular Response After Implantation Of a New Sirolimus-Eluting Stent with Bioabsorbable Polymer (MiStent® DES) – an Optical Coherence Tomography and Histopathological Study.’ Summary: Novel vascular scaffolds aim at equipoise […]
Tzafriri AR. ‘Local drug delivery to the arterial wall: integrating pharmacology with drug transport.’ 1st Modeling Barrier Membranes Research Conference, Frankfurt, Germany, 2011.
Artzi N, Oliva N, Puron C, Shitreet S, Artzi S, bon Ramos A, Groothuis A, Sahagian G, Edelman ER. In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Summary: The design of erodible biomaterials relies on the ability to program the in vivo retention time, which necessitates real-time monitoring of […]
Tzafriri AR, Groothuis A, Price SG, Edelman ER. ‘Stent Elution Rate Determines Sirolimus Deposition and Binding.’ FDA/NHLBI/NSF Workshop on Computer Methods for Cardiovascular Devices, Silver Springs, MD, 2011.
Botta AL. ‘An Alternative Approach to Venous Access for Large Diameter Catheters and Devices in the Swine Model: Using the Iliac Vein.’ Academy of Surgical Research meeting, Austin, TX, 2011.
Kolandaivelu, K., et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Summary: Contrary to popular perception, drug/polymer coatings do not inherently increase acute stent clotting; they reduce thrombosis. However, strut dimensions and positioning relative to the vessel wall are critical factors in modulating stent […]